2019 American Transplant Congress
Adult-to-Adult Living-Donor Liver Transplantation: Towards a Prediction of Three-Month Survival Combining Graft-to-Recipient Weight and MELD in a Caucasian Population
Abdominal Surgery and Transplant Department, Université Catholique de Louvain, Brussels, Belgium
*Purpose: Adult-to-adult living-donor LT (AALDLT) has been proposed to alleviate allograft shortage. However, it is not commonly considered in Western countries due to easier access…2019 American Transplant Congress
Drug Metabolizing Capacity Of The Liver In Liver Donors Recovers Fully By One Month Post Donation
*Purpose: In liver donors, hepatic volume recovers to pre donation values in 2-6 months after surgery. However, there is limited information on the recovery of…2019 American Transplant Congress
Eupatilin Ameliorates Tacrolimus Induced Nephrotoxicity via Inhibiting Apoptosis
Surgery, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea, Republic of
*Purpose: Tacrolimus (FK506) is an immunosuppressant agent that is frequently used to prevent rejection of solid organs upon transplant. However, nephrotoxicity due to apoptosis and…2019 American Transplant Congress
Hyperglycemia Aggravates Acute Liver Injury by Promoting Macrophage NLRP3 Activation via AMPK/mTOR-Dependent Autophagy Inhibition
The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
*Purpose: The detrimental effects of diabetes mellitus/hyperglycemia include an increase in the oxidative stress response and an enhanced inflammatory response. Despite an increased understanding of…2019 American Transplant Congress
Breakthrough Changes in the Access to Transplantation for the Patients with Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
On behalf of the French aHUS Study Group, France, France
*Purpose: Eculizumab has revolutionized the management of atypical Hemolytic Uremic Syndrome (aHUS). In 2012, the French aHUS Study Group issued recommendations to advocate a pro-transplantation…2019 American Transplant Congress
Prevalence of Recurrent and De Novo Glomerular Diseases after Renal Transplantation: A Single Center Experience
Montefiore-Einstein Transplant Center, Scarsdale, NY
*Purpose: Recurrent and de novo glomerular diseases documented to develop in 10-15% of kidney transplant recipients and are the third leading cause of allograft loss.…2019 American Transplant Congress
Pregnancy in Renal Transplant Recipients A Single Center Retrospective Study
*Purpose: Pregnancies after renal transplantation (RT) are classified as high risk and are reported to generate maternal and foetal complications. The aim of this study…2019 American Transplant Congress
Balance between Low DNA Concentration and Structural Damage of Extracellular Matrix during Recellularization Procedure as a Key to Successful Recellularization
Foundation of Research and Science Development, Warsaw, Poland
*Purpose: Recellularization is considered to be a potential way to solve the problem of organ shortage for transplantation. One of the conditions for the use…2019 American Transplant Congress
Engaging Friends and Family in the Care of the Kidney Transplant Candidate: Identifying Needs and Barriers
*Purpose: Research suggests that including social support networks in the kidney transplant education process improves evaluation completions and increases living donor rates, but the optimal…2019 American Transplant Congress
Preoperative Simulation and Rehearsal of Robotic Living Donor Transplant Nephrectomy Using Patient Specific 3D Printed Hydrogel Models
*Purpose: Robotic-assisted kidney transplantation is an innovative application of the robotic surgery platform. Early experiences suggest that it is associated with comparable graft function, less…
- « Previous Page
- 1
- …
- 127
- 128
- 129
- 130
- 131
- …
- 214
- Next Page »